Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
about
Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells.ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alterationInvariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.
P2860
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@ast
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@en
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@nl
type
label
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@ast
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@en
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@nl
prefLabel
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@ast
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@en
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@nl
P2093
P2860
P1433
P1476
Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
@en
P2093
Ayako Nakano
Hiroe Amou
Hirokazu Miki
Kenichiro Yata
Kumiko Kagawa
Kyoko Takeuchi
Masahiro Abe
Shingen Nakamura
Shiro Fujii
P2860
P304
P356
10.1371/JOURNAL.PONE.0031594
P407
P577
2012-02-28T00:00:00Z